CME news from FiercePharma
News
Pfizer to stop funding for-profit CME
Drug companies have been catching flak lately not only for their direct payments and gifts to doctors -- such as speaking fees and travel -- but for funding the kind of continuing medical education Read more...
AMA won't ban industry-funded education
Pharma marketers can sigh with relief. The American Medical Association won't be banning industry-funded CME this year at least. At the association's annual meeting, delegates opted against a Read more...
Arms twisted, pharma promises disclosure
Pharma knows that self-regulation is the best kind. That's why 12 drug and device makers have promised Sen. Chuck Grassley that they are working on plans to disclose CME grants. You know, the money Read more...
Pharma racks up multibillion-dollar marketing bill
Drug marketing spending is staggering when you think about it: companies shell out $5 billion on DTC ads and $19 billion on so-called "doctor education." Their return on investment here Read more...
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends